Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Formin-like protein 2 (FMNL2) is an evolutionarily conserved actin-binding protein from the formin family, primarily involved in modulating cytoskeletal organization. It participates in the formation of actin filaments, cell migration, invasion, polarity, and adhesion. FMNL2 is activated downstream of Rho GTPases like Cdc42 and Rac1. Functionally, FMNL2 regulates filopodia and lamellipodia assembly through its formin homology domains, mediating cell protrusions crucial for migration and extracellular navigation[2][3][6][7]. FMNL2 has clinical relevance in cancer (regulating cell invasion, particularly in breast and colorectal cancer), neurodegenerative (Alzheimer’s disease), cardiovascular, and some ocular diseases (glaucoma)[1][3][4][5][7]. Formin proteins, including FMNL2, are not common direct drug targets, but represent critical nodes in pathways relevant to disease progression and cellular physiology. FMNL2’s potential as a biomarker exists in oncology and neurovascular disease contexts.
For FMNL2-targeting strategies (investigational/restorative): Modulation of actin polymerization; Inhibition or enhancement of cellular migration/invasion via Rho GTPase effector pathways[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Formin-like protein 2 (FMNL2).